| 000 | 01865 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517044358.0 | ||
| 264 | 0 | _c20160722 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1745-7254 | ||
| 024 | 7 |
_a10.1038/aps.2015.42 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQiao, Han | |
| 245 | 0 | 0 |
_aSynergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cSep 2015 |
||
| 300 |
_a1085-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aNaphthoquinones _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aReceptor, Notch1 _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aWang, Ting-yu | |
| 700 | 1 | _aYan, Wei | |
| 700 | 1 | _aQin, An | |
| 700 | 1 | _aFan, Qi-ming | |
| 700 | 1 | _aHan, Xiu-guo | |
| 700 | 1 | _aWang, Yu-gang | |
| 700 | 1 | _aTang, Ting-ting | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 36 _gno. 9 _gp. 1085-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/aps.2015.42 _zAvailable from publisher's website |
| 999 |
_c25132836 _d25132836 |
||